From January to November of 2008, the sales revenue of Chinese manufacturing industry on biological products and biochemical products totaled RMB 64.248 billion, increasing by 29.81% YOY. The growth rate rose by 7.67% YOY. The industry realized a total profit of RMB 7.689 billion, growing by RMB 1.377 billion YOY. The losses of loss-making enterprises reached RMB 554 million, growing by 7.60% YOY. The growth rate rose by 25.89% YOY. The gross profit rate reached 28.17%, dropping by 2.50% YOY. Assets liability ratio of the industry became 44.39%, increasing by 0.63% YOY.
In the whole 2008, the export volume of Chinese human blood and animal blood products, antisera and vaccines totaled 1,632 tons, growing by -29.7% YOY. The growth rate rose by 22.4% YOY. The import volume totaled 8,978 tons, rising by 287.0% YOY. The growth rate increased by 299.4% YOY. The trade deficit reached USD 501.2396 million, increasing by USD 199.4765 million compared with that in the same period of 2007 (USD 301.7631 million).
Chinese State Development and Reform Commission (SDRC) has released another RMB 442 million of the central investment to support the constructions of biological medicine, biological breeding, and biomedical science high-tech industrialization projects, public service conditions of national biological industrial bases.
Source: China Research and Intelligence
If you'd like to copy or quote this article, please keep the source information
To get more information, please visit
http://www.shcri.com/
http://www.shcri.com/
Contacts:
Eileen Gu
China Research and Intelligence
www.shcri.com
Email: eileen@shcri.com
TEL: 86-21-6852-1029 ext.601
86-21-
